Trial intelligence / Profile preview

Vascular function in impaired glucose tolerance – effect of pioglitazone

2006-002084-49Phase 4Completed

Sponsor
Belfast City Hospital
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pioglitazone in prediabetes (2 arms), sponsored by Belfast City Hospital. Primary endpoints: Nitric oxide bioactivity, Adiponectin levels and 1 more. Started Sep 2006; status: completed.

02

Drugs

pioglitazone
03

Conditions

prediabetes

Beyond the preview

Go deeper on 2006-002084-49.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002084-49.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call